drugset

drugset / Trial / NCT01006941

Trichuris Suis Ova Therapy for Relapsing Multiple Sclerosis - a Safety Study

NCT01006941 ↗

Phase 2 Completed 10 enrolled Rigshospitalet, Denmark Copenhagen University Hospital, Hvidovre · collab OvaMed GmbH · collab Statens Serum Institut · collab University of Copenhagen · collab

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The hypothesis of this study is that treatment with Trichuris suis ova will be safe and effective as an oral treatment of patients with relapsing multiple sclerosis.

Timeline

Start: 2010-05
Primary completion: 2011-01
Completion: 2011-09

Publications

Voldsgaard A, Bager P, Garde E, Akeson P, Leffers AM, Madsen CG, Kapel C, Roepstorff A, Thamsborg SM, Melbye M, Siebner H, Sondergaard HB, Sellebjerg F, Sorensen PS. Trichuris suis ova therapy in relapsing multiple sclerosis is safe but without signals of beneficial effect. Mult Scler. 2015 Nov;21(13):1723-9. doi: 10.1177/1352458514568173. Epub 2015 Feb 19.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Trichuris suis ova	Other / unclassified	2500 unknown	Oral

Indications